Stem Cell Therapy for Knee Osteoarthritis: An Alternative to Knee Replacement

Can Mesenchymal Stem Cells Help Treat Knee Arthritis?

Stem cell therapy is now widely available and increasingly recognised as safe. This blog explores the use of mesenchymal stem cells for knee osteoarthritis, commonly described as age related wear and tear of the joint. While stem cells can also be used to treat acute injury, this article focuses specifically on knee osteoarthritis.

The knee joint is relatively straightforward to access via injection, making it suitable for regenerative treatment. In contrast, knee replacement surgery is often more complex and does not always deliver the same consistent outcomes as hip replacement. For patients seeking alternatives to joint replacement, stem cell therapy for knee osteoarthritis is becoming an increasingly discussed option.

What Are Mesenchymal Stem Cells?

Mesenchymal stem cells, often abbreviated to MSCs, are multipotent cells with two defining capabilities: self renewal and differentiation into multiple tissue types.

They are considered central to regenerative medicine because of their ability to support tissue repair and modulate inflammation.

Key Biological Properties of Mesenchymal Stem Cells

Multipotency

MSCs can differentiate into chondrocytes, which form cartilage, osteoblasts, which form bone, adipocytes, which form fat, myocytes, which form muscle, as well as tendon and ligament cells. This makes them particularly relevant in joint degeneration and cartilage damage.

Immunomodulation

MSCs suppress pro inflammatory cytokines and modulate T cell and macrophage activity. This anti inflammatory effect makes them attractive in the treatment of inflammatory joint disease and osteoarthritis.

Cell Signalling

They secrete growth factors, chemokines and cytokines that stimulate local tissue regeneration, even without permanent engraftment. Much of their therapeutic benefit appears to come from this signalling function.

Homing Ability

MSCs can migrate to areas of tissue damage following injection, supporting repair at the site of injury.

Mesenchymal Stem Cells for Knee Osteoarthritis

Multiple systematic reviews and meta analyses suggest that mesenchymal stem cell therapy significantly improves pain, physical function and cartilage quality in patients with knee osteoarthritis.

The benefits appear time dependent. The most pronounced improvements are often observed at 24 month follow up rather than at 6 or 12 months, suggesting progressive biological repair rather than short term symptom relief.

MSC therapy has been shown to produce significant improvement in Lysholm scores, a recognised measure of knee function. The strongest evidence currently supports use in mild to moderate knee osteoarthritis. Patients with late stage osteoarthritis may still experience benefit, although improvements tend to be more modest.

Safety Profile of Stem Cell Therapy for Knee Arthritis

Although the overall quality of evidence is currently rated as low due to study design limitations, the safety profile of mesenchymal stem cell therapy is generally favourable.

There have been no reports of serious adverse events or tumour formation in the reviewed literature. The most commonly reported side effects are transient joint pain and swelling following injection.

Are Stem Cells a Viable Alternative to Knee Replacement?

Given the growing body of evidence supporting their effectiveness, combined with their relative ease of administration via joint injection, mesenchymal stem cells represent a viable treatment option for selected patients with knee osteoarthritis.

For individuals seeking to delay or avoid knee replacement surgery, stem cell therapy may offer a regenerative approach focused on cartilage repair, inflammation reduction and functional improvement.

Dr Tim Trodd

Family Medicine, Functional Medicine, General Practice

MBBS (London)
DCH (London)
DRCOG (UK)
MRCGP (UK)
FHKAM (Family Medicine)

View Profile View Reports & Publications

Health Articles by Dr Tim Trodd

Interviews

References

Freitag J, Bates D, Wickham J, Shah K, Huguenin L, Tenen A, Paterson K and Boyd R (2019) Adipose‑derived mesenchymal stem cell therapy in the treatment of knee osteoarthritis: a randomised controlled trial. Regenerative Medicine, 14(3), pp.213–230. doi:10.2217/rme-2018-0161.
Lamo‑Espinosa JM, Mora G, Blanco JF, Granero‑Moltó F, Núñez‑Córdoba JM, López‑Elío S, Andreu E, Sánchez‑Guijo F, Aquerreta JD, Bondía JM, Valentí‑Azcárate A, Del Cañizo MDC, Villarón EM, Valentí‑Nin JR and Prósper F (2018) Intra‑articular injection of two different doses of autologous bone marrow mesenchymal stem cells versus hyaluronic acid in the treatment of knee osteoarthritis: long‑term follow‑up of a multicentre randomised controlled clinical trial (phase I/II). Journal of Translational Medicine, 16(1), 213. doi:10.1186/s12967-018-1591-7.
Raman N, Imran SAM, Ahmad Amin Noordin KB, Wan Kamarul Zaman WS and Nordin F (2022) Mechanotransduction of mesenchymal stem cells (MSCs) during cardiomyocytes differentiation. Heliyon, 8(11), p.e11624. doi:https://doi.org/10.1016/j.heliyon.2022.e11624.
Song Y, Du H, Dai C, Zhang L, Li S, Hunter DJ, Lu L and Bao C (2018) Human adipose‑derived mesenchymal stem cells for osteoarthritis: a pilot study with long‑term follow‑up and repeated injections. Regenerative Medicine, 13(3), pp.295–307. doi:10.2217/rme-2017-0152.
Ullah M, Liu DD and Thakor AS (2019) Mesenchymal stromal cell homing: mechanisms and strategies for improvement. iScience, 15, pp.421–438. doi:https://doi.org/10.1016/j.isci.2019.05.004.
Wang J, Xue H, Shi M and Chen R (2026) Mesenchymal stem cell-based therapy for osteoarthritis: a systematic review and meta-analysis of clinical outcomes and functional recovery. Frontiers in Cell and Developmental Biology, 13. doi:https://doi.org/10.3389/fcell.2025.1746471.
Zhu C, Wu W and Qu X (2021) Mesenchymal stem cells in osteoarthritis therapy: a review. American Journal of Translational Research, 13(2), pp.448–461. Available at: https://pmc.ncbi.nlm.nih.gov/articles/PMC7868850/